We conclude that a strategy of combined inhibition of both Galectin-1 and Galectin-3 function, both extracellularly and intracellularly, using small molecule inhibitors, would seem to be particularly effective to chemo-sensitize BCP-ALL cells. Here, LGALS1 is linked to acute lymphoblastic leukemia.